Indefinite Delivery Contract HHSD200200929441I
Award Date 4/24/09
Last Date to Order 2/28/10
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Glaxosmithkline Holdings (Americas) Inc. The contract, identified as HHSD200200930521I, has a ceiling value of $809,252,070.00 and a period of performance from July 1, 2009 to June 30, 2010. The contract, known as VFA 2009, does not have any set-asides and was awarded as a multiple-award vehicle....
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Novartis Vaccines And Diagnostics, Inc., a foreign-owned for-profit organization. The $4,555,107.50 contract was a single award with a performance period ending on February 28, 2011. The IDC was awarded to provide TAS FLU 2010 VFA services, though the specific products and services to be delivered are not detailed in the...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...
- The federal contract IDV being summarized is a multiple award Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc. for the delivery of adult influenza vaccines for the 2024-2025 flu season. The $215,741,000 IDC covers a range of influenza vaccine products and presentations, including multi-dose vials, pre-filled syringes, and specialized formulations for different age groups. Seqirus, a foreign-owned for-profit manufacturer,...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The single-award contract has a ceiling value of $11,968,367.50 and a period of performance from March 15, 2010 to February 28, 2011. The contract aims to procure influenza vaccine services for the CDC's Vaccine for Children (VFC) program in 2010. The VFC program provides vaccines at no cost to...
- This federal contract IDV award was issued by the Defense agency Medical Supply Chain to the prime contractor Medimmune, LLC for the procurement of influenza virus vaccines. The contract was a single-award, indefinite delivery contract with a total ceiling value of $23,900,000. The contract included numerous firm-fixed price task orders for the delivery of influenza vaccines to the Shepherdsville, KY area, with individual task order values ranging from a few thousand to over $100,000. The...
- This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, aims to procure products and services related to the FLU 2009 Vaccine Formal Agreement (FLU 2009 VFA) program. The single-award contract, which has a ceiling value of $18,843,626.15 and a period of performance ending on February 28, 2010, was awarded to GlaxoSmithKline Holdings (Americas) Inc. on April 24, 2009. The contract does not...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The contract has a ceiling value of $20,661,104.25 and a period of performance from March 15, 2010 to February 28, 2011. The contract appears to be for the procurement of flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program. While the exact scope...
- The federal contract IDV award was issued by a U.S. federal government agency to Novartis Vaccines And Diagnostics, Inc., a foreign-owned, for-profit organization. The contract type is an Indefinite Delivery Contract with a potential value of $3,378,319.52. The contract's description is "BIOMEDICAL (BASIC)," indicating it is for basic biomedical products and services. Under this IDV, a single task order was issued with a potential value of $76,625,000.00. This task order, also for...
- The federal contract IDV award was granted to Sanofi Pasteur Inc., a vaccine and pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency. The single-award Indefinite Delivery Contract, valued at up to $9,702,459.30, covers the delivery of various vaccine products and services to support public health preparedness and disease prevention missions of multiple government agencies. This includes seasonal and...